CTI BioPharma Ratios and Metrics

Market cap in millions VND. Fiscal year is April - March.

Millions VND. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Aug '25 Aug 4, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Apr '23 Apr 1, 2023	Apr '22 Apr 1, 2022	Apr '21 Apr 1, 2021	2016 - 2020
Market Capitalization	118,723	175,886	208,132	233,049	266,760	307,800	Upgrade
Market Cap Growth	-15.49%	-15.49%	-10.69%	-12.64%	-13.33%	-18.61%	Upgrade
Enterprise Value	51,097	121,403	163,511	214,635	243,682	282,498	Upgrade
Last Close Price	8100.00	12000.00	14200.00	15900.00	18200.00	21000.00	Upgrade
PE Ratio	126.08	354.31	-	-	81.96	26.88	Upgrade
PS Ratio	1.60	2.44	1.03	1.24	1.10	1.05	Upgrade
PB Ratio	0.69	1.02	1.21	1.22	1.29	1.51	Upgrade
P/TBV Ratio	0.69	1.02	1.21	1.22	1.29	1.51	Upgrade
P/FCF Ratio	19.55	-	2.72	-	-	4.06	Upgrade
P/OCF Ratio	19.41	-	2.72	-	-	3.70	Upgrade
EV/Sales Ratio	0.69	1.69	0.81	1.15	1.01	0.96	Upgrade
EV/EBITDA Ratio	13.96	36.94	-	-	20.66	14.34	Upgrade
EV/EBIT Ratio	-	-	-	-	54.07	21.74	Upgrade
EV/FCF Ratio	8.41	-	2.14	-	-	3.73	Upgrade
Debt / Equity Ratio	-	-	0.00	0.06	0.08	0.02	Upgrade
Debt / EBITDA Ratio	-	-	-	-	1.33	0.22	Upgrade
Debt / FCF Ratio	-	-	0.00	-	-	0.06	Upgrade
Asset Turnover	0.41	0.41	1.04	0.84	1.07	1.21	Upgrade
Inventory Turnover	1.40	1.40	2.53	1.49	2.26	2.19	Upgrade
Quick Ratio	15.61	15.61	16.55	1.65	1.70	3.74	Upgrade
Current Ratio	28.08	28.08	25.13	8.89	6.11	9.52	Upgrade
Return on Equity (ROE)	0.29%	0.29%	-10.64%	-8.19%	1.58%	5.78%	Upgrade
Return on Assets (ROA)	-0.77%	-0.77%	-7.20%	-3.17%	1.24%	3.35%	Upgrade
Return on Capital (ROIC)	-0.79%	-0.79%	-7.46%	-3.32%	1.31%	3.61%	Upgrade
Return on Capital Employed (ROCE)	-	-	-	-	2.20%	6.40%	Upgrade
Earnings Yield	0.79%	0.28%	-9.25%	-6.99%	1.22%	3.72%	Upgrade
FCF Yield	5.11%	-3.25%	36.78%	-4.30%	-9.88%	24.64%	Upgrade
Payout Ratio	-	-	-	-	-	0.17%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.